Adtalem Global Education Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings per Share
- Earnings per Share
The following table sets forth the computations of basic and diluted earnings per share and antidilutive shares (in thousands, except per share data):
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, | |||||||||
| · · 2025 · · 2024 · · 2023 | |||||||||
| Numerator: | | | | | | | | | |
| Net income (loss): · · · · · · | |||||||||
| Continuing operations | | $232,677 | | $137,713 | | $101,752 | |||
| Discontinued operations | | | 4,388 | | | (936) | | | (8,394) |
| Net income | | $237,065 | | $136,777 | | $93,358 | |||
| | | | | | | | | | |
| Denominator: | | | | | | | | | |
| Weighted-average basic shares outstanding | | | 37,085 | | 39,413 | | 44,781 | ||
| Effect of dilutive stock awards | | | 1,249 | | 894 | | 743 | ||
| Effect of ASR | | | — | | — | | 76 | ||
| Weighted-average diluted shares outstanding | | | 38,334 | | 40,307 | | 45,600 | ||
| | | | | | | | | | |
| Earnings (loss) per share: | | | | | | | | | |
| Basic: | | | | | | | | | |
| Continuing operations | | $6.27 | | $3.49 | | $2.27 | |||
| Discontinued operations | | $0.12 | | $(0.02) | | $(0.19) | |||
| Total basic earnings per share | | $6.39 | | $3.47 | | $2.08 | |||
| Diluted: | | | | | | | | | |
| Continuing operations | | $6.07 | | $3.42 | | $2.23 | |||
| Discontinued operations | | $0.11 | | $(0.02) | | $(0.18) | |||
| Total diluted earnings per share | | $6.18 | | $3.39 | | $2.05 | |||
| | | | | | | | | | |
| Weighted-average antidilutive shares | | | 23 | | | 115 | | | 403 |
As further described in Note 14 “Share Repurchases,” on March 14, 2022, we entered into an accelerated share repurchase (“ASR”) agreement to repurchase $150.0 million of common stock. For purposes of calculating earnings per share, Adtalem reflected the ASR agreement as a repurchase of Adtalem common stock and as a forward contract indexed to its own common stock. Based on the volume-weighted average price of Adtalem’s common stock per the terms of the ASR agreement, common stock of 76 thousand shares were contingently issuable by Adtalem under the ASR agreement and were included in the diluted earnings per share calculation for fiscal year 2023 because the effect would have been dilutive. As of October 14, 2022, the ASR agreement is no longer outstanding. Diluted earnings per share was computed using the treasury stock method for stock awards.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.